Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet - Organon (NYSE:OGN)

Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet - Organon (NYSE:OGN)

Mumbai-based Dilip Shanghvi-led Sun Pharmaceutical Industries is moving closer to a binding $12 billion offer for Organon & Co. (NYSE:OGN), marking what could become the largest overseas acquisition by an Indian pharmaceutical company. Sun Pharma Advances Toward Final Organon Offer Citing people familiar with the matter, the Economic Times reported that Sun Pharma has completed an extensive due diligence process spanning more than three months. …

Organon rises as Sun Pharma nears buyout deal (OGN:NYSE)

Organon (OGN) stock jumps as reports say Sun Pharma made a $12B binding offer for the company after completing due diligence. Read more here.

Organon Stock Explodes 17% on Takeover Speculation as Women's Health Drugmaker Draws Buyer Interest

Shares of Organon & Co. skyrocketed more than 17% in early trading Friday, April 10, 2026, surging to $8.12 as rumors of a potential takeover bid circulated on Wall Street, injecting fresh excitement into the struggling women's health pharmaceutical company that has languished near multi-year lows for much of the year.